Condition

Coronary Arterial Disease

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting2

Common interventions2

Lead sponsors shown2

Clinical trials

2 shown

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass GraftingNCT07601867 · 2026-07-01

RECRUITING

Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionNCT07683585 · 2026-04-01

RECRUITING

Common interventions

Amlodipine + AzilsartanDRUG1 Losartan + HydrochlorothiazideDRUG1

Leading sponsors

National Medical Research Center for Therapy and Preventive Medicine1 Pyatigorsk City Clinical Hospital Number 11

Trial status mix

RECRUITING2

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.